Dr. Berga explains how transdermal estrogen and oral estrogen decrease harmful side effects for women.
Well, given that we don’t know everything yet, what we do as doctors when we don’t know everything is think about how the body does it. We call that physiology and transdermal or non-oral hormone delivery tend to approximate what the body does better than oral routes of delivery and that’s a complicated explanation, but it is true that transdermal leads to consequences that are good, like a lower blood pressure, like steady-state levels, like lack of accumulation of metabolites that are harmful and so forth and so on.
So, transdermal replicates physiology better than oral and it seems to give a better impact, a better side effect profile.
About Dr. Berga, M.D.:
Dr. Sarah Berga is professor and chairman in the Department of Gynecology and Obstetrics at Emory University School of Medicine. She is board certified in obstetrics and gynecology, and reproductive endocrinology. She received her undergraduate degree at the University of Virginia and later held an Obstetrics and Gynecology General Hospital Fellowship at Harvard Medical School. Dr. Berga’s research focuses on understanding the impact of psychogenic and metabolic stresses upon the reproductive system and as a cause of infertility, among other topics.
View Dr. Berga Videos:
Visit Dr. Berga at Emory University